{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:19:20Z","timestamp":1784557160546,"version":"3.55.0"},"reference-count":92,"publisher":"Bioscientifica","issue":"2","content-domain":{"domain":["joe.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"abstract":"<jats:p>Adamantinomatous craniopharyngiomas (ACP) are clinically relevant tumours that are associated with high morbidity, poor quality of life and occasional mortality. Human and mouse studies have provided important insights into the biology of these aggressive tumours, and we are starting to understand why, how and when these tumours develop in humans. Mutations in \u03b2-catenin that result in the over-activation of the WNT\/\u03b2-catenin signalling pathway are critical drivers of most, perhaps of all, human ACPs. Mouse studies have shown that only pituitary embryonic precursors or adult stem cells are able to generate tumours when targeted with oncogenic \u03b2-catenin, which suggests that the cell context is critical in order for mutant \u03b2-catenin to exert its oncogenic effect. Interestingly, mutant stem cells do not generate the bulk of the tumour cells; instead, they induce tumours in a paracrine manner. Combining basic studies in mice and humans will provide further insights into the biology of these neoplasms and will reveal pathogenic pathways that could be targeted with specific inhibitors for the benefit of patients. These benign tumours may additionally represent a unique model for investigating the early steps that lead to oncogenesis.<\/jats:p>","DOI":"10.1530\/joe-15-0145","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T22:41:32Z","timestamp":1430347292000},"page":"T161-T172","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":25,"title":["60 YEARS OF NEUROENDOCRINOLOGY: Biology of human craniopharyngioma: lessons from mouse models"],"prefix":"10.1530","volume":"226","author":[{"given":"Juan Pedro","family":"Martinez-Barbera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2015072420351657000_226.2.T161.1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.13.3797"},{"key":"2015072420351657000_226.2.T161.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0720-048X(97)00086-7"},{"key":"2015072420351657000_226.2.T161.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3419"},{"key":"2015072420351657000_226.2.T161.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-012-0957-9"},{"key":"2015072420351657000_226.2.T161.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.07.004"},{"key":"2015072420351657000_226.2.T161.6","doi-asserted-by":"crossref","unstructured":"Aquilina K O'Brien DF Farrell MA Bolger C 2006 Primary cerebellopontine angle craniopharyngioma in a patient with gardner syndrome. Case report and review of the literature. Journal of Neurosurgery 105 330\u2013333. (doi:10.3171\/jns.2006.105.2.330)","DOI":"10.3171\/jns.2006.105.2.330"},{"key":"2015072420351657000_226.2.T161.7","doi-asserted-by":"crossref","unstructured":"Aquilina K Merchant TE Rodriguez-Galindo C Ellison DW Sanford RA Boop FA 2010 Malignant transformation of irradiated craniopharyngioma in children: report of 2 cases. Journal of Neurosurgery. Pediatrics 5 155\u2013161. (doi:10.3171\/2009.9.PEDS09257)","DOI":"10.3171\/2009.9.PEDS09257"},{"key":"2015072420351657000_226.2.T161.8","doi-asserted-by":"crossref","unstructured":"Babovic S Eaves CJ 2014 Hierarchical organization of fetal and adult hematopoietic stem cells. Experimental Cell Research 329 185\u2013191. (doi:10.1016\/j.yexcr.2014.08.005)","DOI":"10.1016\/j.yexcr.2014.08.005"},{"key":"2015072420351657000_226.2.T161.9","doi-asserted-by":"crossref","unstructured":"Bartels U Laperriere N Bouffet E Drake J 2012 Intracystic therapies for cystic craniopharyngioma in childhood. Frontiers in Endocrinology 3 39. (doi:10.3389\/fendo.2012.00039)","DOI":"10.3389\/fendo.2012.00039"},{"key":"2015072420351657000_226.2.T161.10","doi-asserted-by":"publisher","DOI":"10.1038\/483531a"},{"key":"2015072420351657000_226.2.T161.11","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01885-08"},{"key":"2015072420351657000_226.2.T161.12","doi-asserted-by":"crossref","unstructured":"Blanco Calvo M Bolos Fernandez V Medina Villaamil V Aparicio Gallego G Diaz Prado S Grande Pulido E 2009 Biology of BMP signalling and cancer. Clinical and Translational Oncology 11 126\u2013137. (doi:10.1007\/S12094-009-0328-8)","DOI":"10.1007\/S12094-009-0328-8"},{"key":"2015072420351657000_226.2.T161.13","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2007.060155"},{"key":"2015072420351657000_226.2.T161.14","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2868"},{"key":"2015072420351657000_226.2.T161.15","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.89.4.0547"},{"key":"2015072420351657000_226.2.T161.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-005-1004-x"},{"key":"2015072420351657000_226.2.T161.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-006-0184-3"},{"key":"2015072420351657000_226.2.T161.18","doi-asserted-by":"crossref","unstructured":"Cao J Lin JP Yang LX Chen K Huang ZS 2010 Expression of aberrant \u03b2-catenin and impaired p63 in craniopharyngiomas. British Journal of Neurosurgery 24 249\u2013256. (doi:10.3109\/02688690903576237)","DOI":"10.3109\/02688690903576237"},{"key":"2015072420351657000_226.2.T161.19","doi-asserted-by":"crossref","unstructured":"Cohen M Guger S Hamilton J 2011 Long term sequelae of pediatric craniopharyngioma \u2013 literature review and 20 years of experience. Frontiers in Endocrinology 2 81. (doi:10.3389\/fendo.2011.00081)","DOI":"10.3389\/fendo.2011.00081"},{"key":"2015072420351657000_226.2.T161.20","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not026"},{"key":"2015072420351657000_226.2.T161.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2011.01.010"},{"key":"2015072420351657000_226.2.T161.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.05.016"},{"key":"2015072420351657000_226.2.T161.23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707886105"},{"key":"2015072420351657000_226.2.T161.24","doi-asserted-by":"crossref","unstructured":"Fedorenko IV Gibney GT Sondak VK Smalley KS 2015 Beyond BRAF: where next for melanoma therapy? British Journal of Cancer 112 217\u2013226. (doi:10.1038\/bjc.2014.476)","DOI":"10.1038\/bjc.2014.476"},{"key":"2015072420351657000_226.2.T161.25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004815"},{"key":"2015072420351657000_226.2.T161.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1101553108"},{"key":"2015072420351657000_226.2.T161.27","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0934"},{"key":"2015072420351657000_226.2.T161.28","unstructured":"Gong J Zhang H Xing S Li C Ma Z Jia G Hu W 2014 High expression levels of CXCL12 and CXCR4 predict recurrence of adamantinomatous craniopharyngiomas in children. Cancer Biomarkers 14 241\u2013251. (doi:10.3233\/CBM-140397)"},{"key":"2015072420351657000_226.2.T161.29","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(92)90023-2"},{"key":"2015072420351657000_226.2.T161.30","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(92)90235-Z"},{"key":"2015072420351657000_226.2.T161.31","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000213328.64121.12"},{"key":"2015072420351657000_226.2.T161.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2008.00180.x"},{"key":"2015072420351657000_226.2.T161.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0642-9"},{"key":"2015072420351657000_226.2.T161.34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2811"},{"key":"2015072420351657000_226.2.T161.35","doi-asserted-by":"crossref","unstructured":"Hussain I Eloy JA Carmel PW Liu JK 2013 Molecular oncogenesis of craniopharyngioma: current and future strategies for the development of targeted therapies. Journal of Neurosurgery 119 106\u2013112. (doi:10.3171\/2013.3.JNS122214)","DOI":"10.3171\/2013.3.JNS122214"},{"key":"2015072420351657000_226.2.T161.36","doi-asserted-by":"crossref","unstructured":"Iannalfi A Fragkandrea I Brock J Saran F 2013 Radiotherapy in craniopharyngiomas. Clinical Oncology 25 654\u2013667. (doi:10.1016\/j.clon.2013.07.005)","DOI":"10.1016\/j.clon.2013.07.005"},{"key":"2015072420351657000_226.2.T161.37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1429"},{"key":"2015072420351657000_226.2.T161.38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64311"},{"key":"2015072420351657000_226.2.T161.39","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4233"},{"key":"2015072420351657000_226.2.T161.40","doi-asserted-by":"crossref","unstructured":"Karavitaki N 2014 Management of craniopharyngiomas. Journal of Endocrinological Investigation 37 219\u2013228. (doi:10.1007\/s40618-013-0050-9)","DOI":"10.1007\/s40618-013-0050-9"},{"key":"2015072420351657000_226.2.T161.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02231.x"},{"key":"2015072420351657000_226.2.T161.42","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(92)90150-7"},{"key":"2015072420351657000_226.2.T161.43","doi-asserted-by":"publisher","DOI":"10.1002\/path.1562"},{"key":"2015072420351657000_226.2.T161.44","doi-asserted-by":"crossref","unstructured":"Kiehna EN Merchant TE 2010 Radiation therapy for pediatric craniopharyngioma. Neurosurgical Focus 28 E10. (doi:10.3171\/2010.1.FOCUS09297)","DOI":"10.3171\/2010.1.FOCUS09297"},{"key":"2015072420351657000_226.2.T161.45","doi-asserted-by":"publisher","DOI":"10.1038\/nature12883"},{"key":"2015072420351657000_226.2.T161.46","doi-asserted-by":"crossref","unstructured":"Kostadinov S Hanley CL Lertsburapa T O'Brien B He M 2014 Fetal craniopharyngioma: management, postmortem diagnosis, and literature review of an intracranial tumor detected in utero . Pediatric and Developmental Pathology 17 409\u2013412. (doi:10.2350\/14-06-1506-CR.1)","DOI":"10.2350\/14-06-1506-CR.1"},{"key":"2015072420351657000_226.2.T161.47","doi-asserted-by":"crossref","unstructured":"Larkin SJ Ansorge O 2013 Pathology and pathogenesis of craniopharyngiomas. Pituitary 16 9\u201317. (doi:10.1007\/s11102-012-0418-4)","DOI":"10.1007\/s11102-012-0418-4"},{"key":"2015072420351657000_226.2.T161.48","doi-asserted-by":"crossref","unstructured":"Larkin SJ Preda V Karavitaki N Grossman A Ansorge O 2014 BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Acta Neuropathologica 127 927\u2013929. (doi:10.1007\/s00401-014-1270-6)","DOI":"10.1007\/s00401-014-1270-6"},{"key":"2015072420351657000_226.2.T161.49","unstructured":"Larsen W 2001 Human Embryology, 3rd Edition, pp 419\u2013423. Philadelphia, PA, USA: Saunders."},{"key":"2015072420351657000_226.2.T161.50","doi-asserted-by":"crossref","unstructured":"Liu W Fang Y Cai B Xu J You C Zhang H 2012 Intracystic bleomycin for cystic craniopharyngiomas in children (abridged republication of cochrane systematic review). Neurosurgery 71 909\u2013915. (doi:10.1227\/NEU.0b013e31826d5c31)","DOI":"10.1227\/NEU.0b013e31826d5c31"},{"key":"2015072420351657000_226.2.T161.51","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12171"},{"key":"2015072420351657000_226.2.T161.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.03.020"},{"key":"2015072420351657000_226.2.T161.53","unstructured":"Mak IW Evaniew N Ghert M 2014 Lost in translation: animal models and clinical trials in cancer treatment. American Journal of Translational Research 6 114\u2013118."},{"key":"2015072420351657000_226.2.T161.54","doi-asserted-by":"crossref","unstructured":"Martinez-Barbera JP Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma Neuropathology and Applied Neurobiology 2015 [in press] doi:10.1111\/nan.12226)","DOI":"10.1111\/nan.12226"},{"key":"2015072420351657000_226.2.T161.55","doi-asserted-by":"crossref","unstructured":"Martinez-Barbera JP Buslei R 2015 Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models. Journal of Pediatric Endocrinology & Metabolism 28 7\u201317. (doi:10.1515\/jpem-2014-0442)","DOI":"10.1515\/jpem-2014-0442"},{"key":"2015072420351657000_226.2.T161.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.12.001"},{"key":"2015072420351657000_226.2.T161.57","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70072-5"},{"key":"2015072420351657000_226.2.T161.58","unstructured":"Merchant TE 2006 Craniopharyngioma radiotherapy: endocrine and cognitive effects. Journal of Pediatric Endocrinology & Metabolism 19 (Suppl 1) 439\u2013446."},{"key":"2015072420351657000_226.2.T161.59","doi-asserted-by":"crossref","unstructured":"Muller HL 2010a Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up. Expert Review of Neurotherapeutics 10 515\u2013524. (doi:10.1586\/ern.10.15)","DOI":"10.1586\/ern.10.15"},{"key":"2015072420351657000_226.2.T161.60","doi-asserted-by":"crossref","unstructured":"Muller HL 2010b Childhood craniopharyngioma \u2013 current concepts in diagnosis, therapy and follow-up. Nature Reviews. Endocrinology 6 609\u2013618. (doi:10.1038\/nrendo.2010.168)","DOI":"10.1038\/nrendo.2010.168"},{"key":"2015072420351657000_226.2.T161.61","doi-asserted-by":"crossref","unstructured":"Muller HL 2014a Childhood craniopharyngioma: treatment strategies and outcomes. Expert Review of Neurotherapeutics 14 187\u2013197. (doi:10.1586\/14737175.2014.875470)","DOI":"10.1586\/14737175.2014.875470"},{"key":"2015072420351657000_226.2.T161.62","doi-asserted-by":"publisher","DOI":"10.1210\/er.2013-1115"},{"key":"2015072420351657000_226.2.T161.63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031751"},{"key":"2015072420351657000_226.2.T161.64","doi-asserted-by":"crossref","unstructured":"Nguyen LV Vanner R Dirks P Eaves CJ 2012 Cancer stem cells: an evolving concept. Nature Reviews. Cancer 12 133\u2013143. (doi:10.1038\/nrc3184)","DOI":"10.1038\/nrc3184"},{"key":"2015072420351657000_226.2.T161.65","doi-asserted-by":"publisher","DOI":"10.1038\/ng1099"},{"key":"2015072420351657000_226.2.T161.66","doi-asserted-by":"crossref","unstructured":"Nielsen EH Feldt-Rasmussen U Poulsgaard L Kristensen LO Astrup J Jorgensen JO Bjerre P Andersen M Andersen C Jorgensen J 2011 Incidence of craniopharyngioma in Denmark (n=189) and estimated world incidence of craniopharyngioma in children and adults. Journal of Neuro-Oncology 104 755\u2013763. (doi:10.1007\/s11060-011-0540-6)","DOI":"10.1007\/s11060-011-0540-6"},{"key":"2015072420351657000_226.2.T161.67","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-004-5232-z"},{"key":"2015072420351657000_226.2.T161.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.02.046"},{"key":"2015072420351657000_226.2.T161.69","doi-asserted-by":"crossref","unstructured":"Pettorini BL Inzitari R Massimi L Tamburrini G Caldarelli M Fanali C Cabras T Messana I Castagnola M Di Rocco C 2010 The role of inflammation in the genesis of the cystic component of craniopharyngiomas. Child's Nervous System 26 1779\u20131784. (doi:10.1007\/s00381-010-1245-4)","DOI":"10.1007\/s00381-010-1245-4"},{"key":"2015072420351657000_226.2.T161.70","doi-asserted-by":"crossref","unstructured":"Preda V Larkin SJ Karavitaki N Ansorge O Grossman AB 2015 The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis. Endocrine Pathology 26 1\u20138. (doi:10.1007\/s12022-014-9341-8)","DOI":"10.1007\/s12022-014-9341-8"},{"key":"2015072420351657000_226.2.T161.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.12.008"},{"key":"2015072420351657000_226.2.T161.72","doi-asserted-by":"crossref","unstructured":"Ribas A Flaherty KT 2011 BRAF targeted therapy changes the treatment paradigm in melanoma. Nature Reviews. Clinical Oncology 8 426\u2013433. (doi:10.1038\/nrclinonc.2011.69)","DOI":"10.1038\/nrclinonc.2011.69"},{"key":"2015072420351657000_226.2.T161.73","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.2.260"},{"key":"2015072420351657000_226.2.T161.74","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000068866.22176.07"},{"key":"2015072420351657000_226.2.T161.75","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61543-7"},{"key":"2015072420351657000_226.2.T161.76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902903"},{"key":"2015072420351657000_226.2.T161.77","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(01)02048-1"},{"key":"2015072420351657000_226.2.T161.78","doi-asserted-by":"crossref","unstructured":"Sekine S Shibata T Kokubu A Morishita Y Noguchi M Nakanishi Y Sakamoto M Hirohashi S 2002 Craniopharyngiomas of adamantinomatous type harbor \u03b2-catenin gene mutations. American Journal of Pathology 161 1997\u20132001. (doi:10.1016\/S0002-9440(10)64477-X)","DOI":"10.1016\/S0002-9440(10)64477-X"},{"key":"2015072420351657000_226.2.T161.79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2004.02029.x"},{"key":"2015072420351657000_226.2.T161.80","unstructured":"Sofela AA Hettige S Curran O Bassi S 2014 Malignant transformation in craniopharyngiomas. Neurosurgery 75 306\u2013314.(discussion 314) (doi:10.1227\/NEU.0000000000000380)"},{"key":"2015072420351657000_226.2.T161.81","doi-asserted-by":"crossref","unstructured":"Stache C Holsken A Schlaffer SM Hess A Metzler M Frey B Fahlbusch R Flitsch J Buchfelder M Buslei R 2014 Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse model. Brain Pathology 25 1\u201310. (doi:10.1111\/bpa.12148)","DOI":"10.1111\/bpa.12148"},{"key":"2015072420351657000_226.2.T161.82","doi-asserted-by":"publisher","DOI":"10.3109\/08880019209016590"},{"key":"2015072420351657000_226.2.T161.83","doi-asserted-by":"crossref","unstructured":"Vanhauwaert D Hallaert G Baert E Van Roost D Okito JP Caemaert J 2013 Treatment of cystic craniopharyngioma by endocavitary instillation of yttrium(9)(0) radioisotope \u2013 still a valuable treatment option. Journal of Neurological Surgery. Part A, Central European Neurosurgery 74 307\u2013312. (doi:10.1055\/s-0033-1341413)","DOI":"10.1055\/s-0033-1341413"},{"key":"2015072420351657000_226.2.T161.84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-481135"},{"key":"2015072420351657000_226.2.T161.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.05.007"},{"key":"2015072420351657000_226.2.T161.86","doi-asserted-by":"crossref","unstructured":"Walther V Hiley CT Shibata D Swanton C Turner PE Maley CC 2015 Can oncology recapitulate paleontology? Lessons from species extinctions. Nature Reviews. Clinical Oncology 12 273\u2013285. (doi:10.1038\/nrclinonc.2015.12)","DOI":"10.1038\/nrclinonc.2015.12"},{"key":"2015072420351657000_226.2.T161.87","doi-asserted-by":"crossref","unstructured":"Wang Q Hu Y Li G Sun X 2014 Pituitary stalk interruption syndrome in 59 children: the value of MRI in assessment of pituitary functions. European Journal of Pediatrics 173 589\u2013595. (doi:10.1007\/s00431-013-2214-1)","DOI":"10.1007\/s00431-013-2214-1"},{"key":"2015072420351657000_226.2.T161.88","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20101603"},{"key":"2015072420351657000_226.2.T161.89","doi-asserted-by":"crossref","unstructured":"Wisoff JH 2012 Commentary: Intracystic bleomycin for cystic craniopharyngiomas in children (abridged republication of cochrane systematic review). Neurosurgery 71 E1063\u2013E1064. (doi:10.1227\/NEU.0b013e31826d7c7f)","DOI":"10.1227\/NEU.0b013e31826d7c7f"},{"key":"2015072420351657000_226.2.T161.90","doi-asserted-by":"crossref","unstructured":"Xue L Cai JY Ma J Huang Z Guo MX Fu LZ Shi YB Li WX 2013 Global expression profiling reveals genetic programs underlying the developmental divergence between mouse and human embryogenesis. BMC Genomics 14 568. (doi:10.1186\/1471-2164-14-568)","DOI":"10.1186\/1471-2164-14-568"},{"key":"2015072420351657000_226.2.T161.91","doi-asserted-by":"crossref","unstructured":"Yoshimoto M de Toledo SR da Silva NS Bayani J Bertozzi AP Stavale JN Cavalheiro S Andrade JA Zielenska M Squire JA 2004 Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature. Journal of Neurosurgery 101 85\u201390.","DOI":"10.3171\/ped.2004.101.2.0085"},{"key":"2015072420351657000_226.2.T161.92","doi-asserted-by":"crossref","unstructured":"Zheng J Fang Y Cai BW Zhang H Liu W Wu B Xu JG You C 2014 Intracystic bleomycin for cystic craniopharyngiomas in children. Cochrane Database of Systematic Reviews 9 CD008890. (doi:10.1002\/14651858.CD008890.pub3)","DOI":"10.1002\/14651858.CD008890.pub3"}],"container-title":["Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/226\/2\/T161.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/226\/2\/T161.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:55:01Z","timestamp":1784555701000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/joe\/article\/226\/2\/T161-T172\/22740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,29]]},"references-count":92,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/joe-15-0145","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725457069.793534496","asserted-by":"object"}]},"ISSN":["0022-0795","1479-6805"],"issn-type":[{"value":"0022-0795","type":"print"},{"value":"1479-6805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,29]]}}}